Butorphanol Tartrate Injection USP

Trade Name: ButoVac
Available Strength : 2 mg
Available Combination : Butorphanol Tartrate Injection USP is an opioid analgesic with mixed agonist–antagonist activity, providing effective pain relief with a lower risk of respiratory depression compared to full opioid agonists.
Packing : 5 x 1 ml Amp.
Pack Insert/Leaflet : YES
Therapeutic use : Butorphanol Tartrate Injection USP is an opioid analgesic used for the management of moderate to severe pain. It is commonly administered in postoperative settings, during labor, and for preoperative analgesia, providing rapid pain relief by acting on central opioid receptors, with additional sedative and antitussive effects.
Capacity : 100000

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.